Jushi Holdings (JUSHF) Other Non-Current Liabilities (2020 - 2026)
Jushi Holdings (JUSHF) reported Other Non-Current Liabilities of $186.2 million for Q1 2026, up 397.74% year-over-year from $37.4 million in Q1 2025, and up 460.86% quarter-over-quarter from $33.2 million in Q4 2025.
Jushi Holdings (JUSHF) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 7 years of Other Non-Current Liabilities data on file, last reported at $186.2 million in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $186.2 million, up 397.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $186.2 million (up 397.74% YoY), and the FY2025 annual result was $33.2 million, up 961.54% from the prior year.
- Other Non-Current Liabilities grew to $186.2 million in Q1 2026 per JUSHF's latest filing, from $33.2 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $186.2 million in Q1 2026 and troughed at $344000.0 in Q2 2024.
- A 5-year average of $59.5 million and a median of $37.4 million in 2025 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities plunged 99.43% in 2024, then soared 47221.22% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $14.1 million in 2022, then soared by 640.24% to $104.6 million in 2023, then slumped by 97.01% to $3.1 million in 2024, then jumped by 961.54% to $33.2 million in 2025, then soared by 460.86% to $186.2 million in 2026.
- Business Quant data shows JUSHF's Other Non-Current Liabilities at $186.2 million in Q1 2026, $33.2 million in Q4 2025, and $33.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.23 Mn |
| Dec 31, 2025 | 33.21 Mn |
| Sep 30, 2025 | 33.84 Mn |
| Jun 30, 2025 | 162.79 Mn |
| Mar 31, 2025 | 37.42 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 136.09 Mn |
| Jun 30, 2024 | 344,000.00 |
| Mar 31, 2024 | 27.96 Mn |
| Dec 31, 2023 | 104.63 Mn |
| Sep 30, 2023 | 10.57 Mn |
| Jun 30, 2023 | 60.49 Mn |
| Mar 31, 2023 | 6.10 Mn |
| Dec 31, 2022 | 14.13 Mn |
| Sep 30, 2022 | 62.40 Mn |
| Jun 30, 2022 | 71.10 Mn |
| Mar 31, 2022 | 61.28 Mn |
| Dec 31, 2021 | 92.44 Mn |
| Dec 31, 2020 | 205.36 Mn |